Spis treści:
Spis załączników:
SFA 2023 dividend payment EN.pdf (REPORT)
reklama
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
SFA 2023 dividend payment EN.pdf (REPORT)
przewiń, aby zobaczyć całą tabelę
POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
UNI - EN REPORT No | 79 | / | 2024 | ||||||||
Date of issue: | 2024-08-19 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
Notification of commencement of dividend payment for the year 2023 | |||||||||||
Official market - legal basis | |||||||||||
art. 56. 1. 2 of Act on Public Offering. | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
Sofia, Bulgaria, August 19, 2024 – In accordance with the requirements of art. 100 of LPOS “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 26, 2024 the Company will initiate the payment of the 2023 dividend of 0,09 stotinki voted on the Annual General Meeting of Shareholders held on June 28, 2024. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
SFA 2023 dividend payment EN.pdfSFA_2023_dividend_payment_EN.pdf | Notification of commencement of dividend payment for the year 2023 |
przewiń, aby zobaczyć całą tabelę
SOPHARMA AD | |||||||||||||
(fullname of the issuer) | |||||||||||||
SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) |
||||||||||||
1220 | Sofia | ||||||||||||
(post code) | (city) | ||||||||||||
IlienskoShosse | 16 | ||||||||||||
(street) | (number) | ||||||||||||
+359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nd | |||||||||||||
(NIP) | (REGON) |
przewiń, aby zobaczyć całą tabelę
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2024-08-19 | Ognian Donev | Executive director |